MX2017016252A - Vacunas de pestivirus para temblores congenitos. - Google Patents

Vacunas de pestivirus para temblores congenitos.

Info

Publication number
MX2017016252A
MX2017016252A MX2017016252A MX2017016252A MX2017016252A MX 2017016252 A MX2017016252 A MX 2017016252A MX 2017016252 A MX2017016252 A MX 2017016252A MX 2017016252 A MX2017016252 A MX 2017016252A MX 2017016252 A MX2017016252 A MX 2017016252A
Authority
MX
Mexico
Prior art keywords
pestivirus
vaccine
congenital tremors
methods
diseases associated
Prior art date
Application number
MX2017016252A
Other languages
English (en)
Inventor
V Iyer Arun
Rae Patterson Abby
Gilbert Victoria Joseph
Ann Visek Callie
Ann Hobbs Lea
Lauren Arruda Bailey
Henrique Elias ARRUDA Paulo
Robert MAGSTADT Drew
jay schwartz Kent
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56889250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2017016252(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of MX2017016252A publication Critical patent/MX2017016252A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente invención se refiere a una vacuna para proteger a un lechón contra enfermedades asociadas con un nuevo pestivirus. La vacuna normalmente incluye un antígeno de pestivirus y, opcionalmente, un adyuvante. También se proveen métodos para proteger a los lechones contra enfermedades asociadas con el pestivirus, incluyendo sin embargo sin limitarse a, temblores congénitos y métodos para producir la vacuna de pestivirus.
MX2017016252A 2015-08-31 2016-08-31 Vacunas de pestivirus para temblores congenitos. MX2017016252A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562212124P 2015-08-31 2015-08-31
PCT/US2016/049709 WO2017040672A1 (en) 2015-08-31 2016-08-31 Pestivirus vaccines for congenital tremors

Publications (1)

Publication Number Publication Date
MX2017016252A true MX2017016252A (es) 2018-04-20

Family

ID=56889250

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017016252A MX2017016252A (es) 2015-08-31 2016-08-31 Vacunas de pestivirus para temblores congenitos.

Country Status (21)

Country Link
US (2) US9920302B2 (es)
EP (1) EP3344289B1 (es)
JP (1) JP7046607B2 (es)
KR (1) KR20180042167A (es)
CN (1) CN108135993B (es)
AU (1) AU2016315796B2 (es)
BR (1) BR112017028224A2 (es)
CA (1) CA2996629A1 (es)
CL (1) CL2018000513A1 (es)
DK (1) DK3344289T3 (es)
EA (1) EA036116B1 (es)
ES (1) ES2778649T3 (es)
HK (1) HK1256205A1 (es)
MX (1) MX2017016252A (es)
MY (1) MY189501A (es)
PH (1) PH12017501795B1 (es)
PL (1) PL3344289T3 (es)
PT (1) PT3344289T (es)
TW (1) TWI799365B (es)
UA (1) UA124140C2 (es)
WO (1) WO2017040672A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
ES2778649T3 (es) * 2015-08-31 2020-08-11 Boehringer Ingelheim Vetmedica Gmbh Vacunas pestivirales para temblores congénitos
CN106801109B (zh) * 2017-03-24 2021-03-05 温氏食品集团股份有限公司 一种猪非典型瘟病毒rt-pcr检测特异性引物、试剂盒及检测方法
CN109295014B (zh) * 2018-10-30 2021-08-17 华中农业大学 一种非典型猪瘟病毒e2蛋白重组杆状病毒及其制备方法和应用

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US382425A (en) 1888-05-08 Brandt
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3456053A (en) * 1966-05-06 1969-07-15 Pfizer & Co C Inactivated hog cholera virus vaccine
US4394448A (en) 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4769331A (en) 1981-09-16 1988-09-06 University Patents, Inc. Recombinant methods and materials
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5364773A (en) 1991-03-07 1994-11-15 Virogenetics Corporation Genetically engineered vaccine strain
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4769330A (en) 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
US5338683A (en) 1981-12-24 1994-08-16 Health Research Incorporated Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5833975A (en) 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
JPS60500673A (ja) 1983-03-08 1985-05-09 コモンウエルス　セラム　ラボラトリ−ズ　コミツシヨン 抗原活性を有するアミノ酸配列
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
IE872748L (en) 1986-10-16 1988-04-16 Arjomari Europ Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
WO1990001543A1 (fr) 1988-07-29 1990-02-22 Intracel Corporation Procede d'expression genetique de proteines heterologues par des cellules transfectees in vivo
CA2003300A1 (en) 1988-11-21 1990-05-21 Franklin Volvovitz Skin test and test kit for aids
WO1990011092A1 (en) 1989-03-21 1990-10-04 Vical, Inc. Expression of exogenous polynucleotide sequences in a vertebrate
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5552143A (en) 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
US5591439A (en) 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
GB9001766D0 (en) 1990-01-25 1990-03-28 Univ Court Of The University O Vaccines
EP0575491B1 (en) 1991-03-07 2003-08-13 Virogenetics Corporation Genetically engineered vaccine strain
US5997878A (en) 1991-03-07 1999-12-07 Connaught Laboratories Recombinant poxvirus-cytomegalovirus, compositions and uses
DK0587780T4 (da) 1991-06-06 2008-10-13 Boehringer Ingelheim Vetmed Smitstof, som forårsager Mystery Swine Disease,vaccinepræparater og diagnostiske sæt
DE601062T1 (de) 1991-08-26 1995-05-18 James Edward Collins Vakzine gegen und diagnosemethode für das schweine-unfruchtbarkeits- und atmungs-syndrom (suas).
US6042830A (en) 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
WO1993006211A1 (en) 1991-09-16 1993-04-01 Collins James E Vaccine for mystery swine disease and method for diagnosis thereof
JPH07501049A (ja) 1991-10-14 1995-02-02 アクゾ・ノベル・エヌ・ベー ブタ生殖・呼吸系症候群ワクチン及び診断方法
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
US5846945A (en) 1993-02-16 1998-12-08 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
IL108915A0 (en) 1993-03-18 1994-06-24 Merck & Co Inc Polynucleotide vaccine against influenza virus
FR2711670B1 (fr) 1993-10-22 1996-01-12 Pasteur Institut Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
WO1995020660A2 (en) 1994-01-27 1995-08-03 University Of Massachusetts Medical Center Immunization by inoculation of dna transcription unit
ATE206455T1 (de) 1994-04-11 2001-10-15 Akzo Nobel Nv Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des schweins
WO1995030018A2 (en) 1994-04-29 1995-11-09 Immuno Aktiengesellschaft Recombinant poxviruses with foreign polynucleotides in essential regions
ATE268783T1 (de) 1995-03-14 2004-06-15 Akzo Nobel Nv Expression in der selben zelle von polypeptide vom schweinen reproduktiven und respiratorischen syndrom
EP0871755A1 (en) 1995-03-23 1998-10-21 Cantab Pharmaceuticals Research Limited Vectors for gene delivery
AU737243B2 (en) 1996-07-03 2001-08-16 Merial, Inc. Recombinant canine adenovirus (CAV) containing exogenous DNA
ATE199022T1 (de) 1996-10-09 2001-02-15 Akzo Nobel Nv Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des sweins (prrsv)
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
US6183752B1 (en) 1997-02-05 2001-02-06 Pasteur Merieux Serums Et Vaccins Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
CA2290220C (en) 1998-12-22 2013-11-19 Pfizer Products Inc. An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
DK1149901T3 (da) * 2000-04-21 2006-07-31 Akzo Nobel Nv Mutanter af pestivirus og vacciner indeholdende disse
EP1290016A2 (en) * 2000-06-15 2003-03-12 Purdue Research Foundation Vaccine for congenital tremors in pigs
US6841364B2 (en) 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
CN104178505B (zh) * 2014-09-01 2017-03-08 华中农业大学 一种表达猪瘟病毒e2基因重组病毒及制备方法与应用
BR112017012484B1 (pt) 2014-12-19 2024-02-06 Intervet International B.V Vacina para combater tremor congênito (ct) do grupo a-ii em porcos
WO2016176624A2 (en) 2015-04-30 2016-11-03 Kansas State University Research Foundation Porcine pestvirus, vaccines, and assays
ES2778649T3 (es) * 2015-08-31 2020-08-11 Boehringer Ingelheim Vetmedica Gmbh Vacunas pestivirales para temblores congénitos

Also Published As

Publication number Publication date
AU2016315796A1 (en) 2017-10-19
PL3344289T3 (pl) 2021-01-11
PH12017501795A1 (en) 2018-04-02
EA201792593A1 (ru) 2018-08-31
TWI799365B (zh) 2023-04-21
UA124140C2 (uk) 2021-07-28
WO2017040672A1 (en) 2017-03-09
JP7046607B2 (ja) 2022-04-04
DK3344289T3 (da) 2020-04-14
PH12017501795B1 (en) 2018-04-02
AU2016315796B2 (en) 2022-08-04
TW201718007A (zh) 2017-06-01
US9920302B2 (en) 2018-03-20
CA2996629A1 (en) 2017-03-09
EP3344289A1 (en) 2018-07-11
CN108135993A (zh) 2018-06-08
PT3344289T (pt) 2020-04-02
CN108135993B (zh) 2022-03-22
ES2778649T3 (es) 2020-08-11
US20180171307A1 (en) 2018-06-21
MY189501A (en) 2022-02-16
US10633637B2 (en) 2020-04-28
KR20180042167A (ko) 2018-04-25
US20170058266A1 (en) 2017-03-02
EP3344289B1 (en) 2020-01-29
BR112017028224A2 (pt) 2018-09-11
CL2018000513A1 (es) 2019-01-11
JP2018525324A (ja) 2018-09-06
EA036116B1 (ru) 2020-09-30
HK1256205A1 (zh) 2019-09-13

Similar Documents

Publication Publication Date Title
MX2016012845A (es) Vacuna contra el virus de la diarrea epidemica porcina.
TWD184927S (zh) 頭戴架之部分
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
EP3484508A4 (en) COMPOSITIONS AND METHODS FOR ALPHAVIRUS VACCINATION
MX2017003131A (es) Metodo para la preparacion de 2-alcoxi ciclohexanol.
PH12017501795A1 (en) Pestivirus vaccines for congenital tremors
MY191539A (en) Streptococcal vaccine
EP3308800A4 (en) Adjuvant for vaccines, vaccine, and immunity induction method
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
PH12017500003A1 (en) Vaccine composition for classical swine fever from plant and manufacturing method thereof
SG11201702838SA (en) Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof
MX2020005584A (es) Vacunacion con particulas de replicon y adyuvante oleoso.
UA116697C2 (uk) Композиція для запобігання зараженню видами роду mycoplasma
EP3075393A4 (en) Adjuvant composition, vaccine composition comprising same, and method for producing same
ZA202000574B (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same
MX2016012932A (es) Procedimientos novedosos para inducir una respuesta inmune.
EP3270976A4 (en) VACCINES WITH CD40 LIGAND AS ADJUVANS
EP3104887A4 (en) Vaccines with interleukin-17 as an adjuvant
GB201704417D0 (en) Improved li vaccine adjuvant
MX2018014955A (es) Vacunas atenuadas vivas del virus de la influenza equina.
GB201910794D0 (en) Vaccine
MX2017015279A (es) Exasomas y su uso como vacunas.
IL284249A (en) A preparation that includes a vaccine additive
ZA201701972B (en) Method for preparing a vaccine antigen, resulting vaccine antigen and uses
MX2017002609A (es) Procedimiento mejorado para la preparacion de lacosamida y su intermediario novedoso.